Copyright
©The Author(s) 2015.
World J Gastroenterol. Apr 14, 2015; 21(14): 4169-4177
Published online Apr 14, 2015. doi: 10.3748/wjg.v21.i14.4169
Published online Apr 14, 2015. doi: 10.3748/wjg.v21.i14.4169
Figure 2 Combined metformin and silibinin treatment inhibits protein kinase B phosphorylation by enhancing phosphatase and tensin homolog expression.
Proteins isolated from COLO 205 cells were probed using an antibody against phosphatase and tensin homolog (PTEN) (A) or phosphorylated protein kinase B (p-Akt) (B). The data are expressed as mean ± SE (n = 6 for each group). aP < 0.01 and bP < 0.001 vs Control. Con: Control; Veh: Vehicle; Sili: Silibinin; Met: Metformin; M + S: Metformin and silibinin.
- Citation: Tsai CC, Chuang TW, Chen LJ, Niu HS, Chung KM, Cheng JT, Lin KC. Increase in apoptosis by combination of metformin with silibinin in human colorectal cancer cells. World J Gastroenterol 2015; 21(14): 4169-4177
- URL: https://www.wjgnet.com/1007-9327/full/v21/i14/4169.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i14.4169